Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Deakin

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Frontiers in Immunology|February 2, 2019
Sex and Pubertal Differences in the Type 1 Interferon Pathway Associate With Both X Chromosome Number and Serum Sex Hormone ConcentrationKate Webb, Hannah Peckham, Anna Radziszewska, et al.
Annals of the Rheumatic Diseases|July 18, 2025
Identification and validation of interferon-driven gene signature as a predictor of response to methotrexate in juvenile idiopathic arthritisMelissa Kartawinata, Wei-Yu Lin, Beth Jebson, et al.
Neuropathology and Applied Neurobiology|May 18, 2018
Expression of myxovirus-resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositisS Soponkanaporn, C T Deakin, P W Schutz, et al.
Rheumatology (Oxford, England)|November 4, 2020
Identification and prediction of novel classes of long-term disease trajectories for patients with juvenile dermatomyositis using growth mixture modelsClaire T Deakin, Charalampia Papadopoulou, Liza J McCann, et al.
JAMA Network Open|June 29, 2023
Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in AustraliaClaire T Deakin, Bianca L De Stavola, Geoffrey Littlejohn, et al.
Neuropathology and Applied Neurobiology|November 1, 2018
Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological featuresS A Yasin, P W Schutz, C T Deakin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 24, 2016
Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile DermatomyositisClaire T Deakin, Shireena A Yasin, Stefania Simou, et al.
Diabetes Research and Clinical Practice|May 10, 2025
Trends in use of sodium-glucose cotransporter 2 inhibitors among people with type 2 diabetes following hospitalisation with heart failure: A population-based studyJialing Lin, Tamara Y Milder, Claire T Deakin, et al.
Clinical and Experimental Immunology|December 25, 2024
Type I interferon and mitochondrial dysfunction are associated with dysregulated cytotoxic CD8+ T cell responses in juvenile systemic lupus erythematosusAnna Radziszewska, Hannah Peckham, Restuadi Restuadi, et al.
The Journal of Experimental Medicine|March 6, 2025
Estrogen influences class-switched memory B cell frequency only in humans with two X chromosomesHannah Peckham, Anna Radziszewska, Justyna Sikora, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|February 2, 2019
Sex and Pubertal Differences in the Type 1 Interferon Pathway Associate With Both X Chromosome Number and Serum Sex Hormone ConcentrationKate Webb, Hannah Peckham, Anna Radziszewska, et al.
Annals of the Rheumatic Diseases|July 18, 2025
Identification and validation of interferon-driven gene signature as a predictor of response to methotrexate in juvenile idiopathic arthritisMelissa Kartawinata, Wei-Yu Lin, Beth Jebson, et al.
Neuropathology and Applied Neurobiology|May 18, 2018
Expression of myxovirus-resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositisS Soponkanaporn, C T Deakin, P W Schutz, et al.
Rheumatology (Oxford, England)|November 4, 2020
Identification and prediction of novel classes of long-term disease trajectories for patients with juvenile dermatomyositis using growth mixture modelsClaire T Deakin, Charalampia Papadopoulou, Liza J McCann, et al.
JAMA Network Open|June 29, 2023
Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in AustraliaClaire T Deakin, Bianca L De Stavola, Geoffrey Littlejohn, et al.
Neuropathology and Applied Neurobiology|November 1, 2018
Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological featuresS A Yasin, P W Schutz, C T Deakin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 24, 2016
Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile DermatomyositisClaire T Deakin, Shireena A Yasin, Stefania Simou, et al.
Diabetes Research and Clinical Practice|May 10, 2025
Trends in use of sodium-glucose cotransporter 2 inhibitors among people with type 2 diabetes following hospitalisation with heart failure: A population-based studyJialing Lin, Tamara Y Milder, Claire T Deakin, et al.
Clinical and Experimental Immunology|December 25, 2024
Type I interferon and mitochondrial dysfunction are associated with dysregulated cytotoxic CD8+ T cell responses in juvenile systemic lupus erythematosusAnna Radziszewska, Hannah Peckham, Restuadi Restuadi, et al.
The Journal of Experimental Medicine|March 6, 2025
Estrogen influences class-switched memory B cell frequency only in humans with two X chromosomesHannah Peckham, Anna Radziszewska, Justyna Sikora, et al.
Pageof 5